Filter
1308
Filtered Results: 1308
Text search:
tb
elimination
Featured
Recommendations
110
New Publications
420
Language
Document type
No document type
896
Studies & Reports
167
Guidelines
124
Strategic & Response Plan
46
Manuals
28
Fact sheets
15
Training Material
14
Situation Updates
7
Infographics
7
Resource Platforms
3
Brochures
1
Countries / Regions
Kenya
55
India
51
Global
47
Uganda
35
South Africa
32
Tanzania
31
Liberia
29
Nepal
28
Ethiopia
28
Rwanda
27
Western and Central Europe
26
Namibia
26
Sierra Leone
25
Nigeria
25
Zambia
25
Africa
24
Senegal
22
Bangladesh
21
Malawi
20
Asia
20
Ghana
16
Latin America and the Carribbean
16
Myanmar / Burma
16
Lesotho
15
South–East Asia Region
14
Cambodia
13
Zimbabwe
12
Ukraine
11
Eastern Europe
11
Germany
10
Haiti
9
Philippines
8
Congo, Democratic Republic of
8
East and Southern Africa
8
Russia
8
Botswana
8
Mozambique
7
Argentina
6
Indonesia
6
Benin
5
West and Central Africa
5
Eswatini/ Swaziland
5
Pakistan
5
Colombia
4
Chile
4
Burkina Faso
4
Venezuela
4
Middle East and North Africa
4
Georgia
4
South Sudan
4
Timor Leste/ East Timor
3
Cameroon
3
Iran
3
Jordan
3
Eastern Europe and Central Asia
3
Lebanon
3
Brazil
3
Sudan
3
Central African Republic
3
Iraq
3
Tajikistan
2
Thailand
2
Syria
2
Albania
2
Laos
2
Niger
2
Afghanistan
2
Peru
2
Guinea
2
Saudi Arabia
2
Bolivia
2
Papua New Guinea
2
Somalia
2
Ecuador
2
Madagascar
2
North Macedonia
1
El Salvador
1
Singapore
1
Burundi
1
Morocco
1
Qatar
1
Bulgaria
1
USA
1
Western Pacific Region
1
North America
1
Maldives
1
Tunisia
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Vietnam
1
Moldova
1
Sri Lanka
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
622
Clinical Guidelines
94
Public Health
43
Women & Child Health
29
Key Resources
24
Pharmacy & Technologies
12
Capacity Building
7
Annual Report MEDBOX
1
Toolboxes
TB
267
HIV
194
NTDs
58
AMR
28
COVID-19
17
Pharmacy
17
Refugee
16
Global Health Education
15
Rapid Response
14
Disability
14
Ebola
14
Caregiver
14
Health Financing Toolbox
10
NCDs
10
Polio
10
Mental Health
8
Planetary Health
8
Conflict
8
Natural Hazards
5
Zika
2
Specific Hazards
1
Cholera
1
Social Ethics
1
Health Financing
1
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interventions within their context, closing the gaps in ca...
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
Accessed 7 July 2015
Infection Control Assessment Tool
recommended
Strengthening Parmaceutical Systems. 2nd edition
